Literature DB >> 15964138

Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours.

Declan M Soden1, John O Larkin, Christopher G Collins, Mark Tangney, Simon Aarons, John Piggott, Anthony Morrissey, Colum Dunne, Gerald C O'Sullivan.   

Abstract

Electroporation is the application of very brief electric pulses to cells or tissues to render the cell membranes transiently and reversibly permeable, facilitating cellular uptake of otherwise impermeant molecules. Flexible electrode arrays were developed which may be used with endoscopic and laparoscopic devices for delivery of therapeutic electroporation. Their efficacy in enhancing the delivery of bleomycin, an impermeant drug, was assessed in vitro and in vivo in both human and murine cancer cell lines, and growing tumours (xenografts). These flexible electrodes consistently and predictably deliver the permeabilising electric pulses requisite for in vivo electroporation, and would be suitable for electrochemotherapy of endoluminal tumours when incorporated into an endoscopic delivery system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964138     DOI: 10.1016/j.canlet.2005.03.057

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  From biocontrol to cancer, probiotics and beyond.

Authors:  Colum Dunne
Journal:  Bioengineered       Date:  2012-12-17       Impact factor: 3.269

2.  Electrochemotherapy is effective in the treatment of rat bone metastases.

Authors:  Milena Fini; Francesca Salamanna; Annapaola Parrilli; Lucia Martini; Matteo Cadossi; Melania Maglio; Veronica Borsari
Journal:  Clin Exp Metastasis       Date:  2013-07-07       Impact factor: 5.150

3.  Different Cell Viability Assays Reveal Inconsistent Results After Bleomycin Electrotransfer In Vitro.

Authors:  Baltramiejus Jakštys; Paulius Ruzgys; Mindaugas Tamošiūnas; Saulius Šatkauskas
Journal:  J Membr Biol       Date:  2015-06-16       Impact factor: 1.843

4.  Electrochemotherapy: aspects of preclinical development and early clinical experience.

Authors:  John O Larkin; Christopher G Collins; Simon Aarons; Mark Tangney; Maria Whelan; Seamus O'Reily; Oscar Breathnach; Declan M Soden; Gerald C O'Sullivan
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

5.  Electrodelivery of drugs into cancer cells in the presence of poloxamer 188.

Authors:  Iana Tsoneva; Iordan Iordanov; Annette J Berger; Toma Tomov; Biliana Nikolova; Nikola Mudrov; Martin R Berger
Journal:  J Biomed Biotechnol       Date:  2010-07-25

6.  Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.

Authors:  Sarfraz Ahmad; Garrett Casey; Paul Sweeney; Mark Tangney; Gerald C O'Sullivan
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

Review 7.  Cell and tissue targeting of nucleic acids for cancer gene therapy.

Authors:  Verena Russ; Ernst Wagner
Journal:  Pharm Res       Date:  2007-03-27       Impact factor: 4.580

8.  Electrochemotherapy: a new technological approach in treatment of metastases in the liver.

Authors:  I Edhemovic; E M Gadzijev; E Brecelj; D Miklavcic; B Kos; A Zupanic; B Mali; T Jarm; D Pavliha; M Marcan; G Gasljevic; V Gorjup; M Music; T Pecnik Vavpotic; M Cemazar; M Snoj; G Sersa
Journal:  Technol Cancer Res Treat       Date:  2011-10

9.  Sonochemotherapy of breast adenocarcinoma: an experimental in vivo model.

Authors:  Bahram Yousefian; Seyed Mohammad Firoozabadi; Manijhe Mokhtari-Dizaji
Journal:  J Ultrasound       Date:  2014-08-06

10.  Electrochemotherapy of colorectal liver metastases--an observational study of its effects on the electrocardiogram.

Authors:  Barbara Mali; Vojka Gorjup; Ibrahim Edhemovic; Erik Brecelj; Maja Cemazar; Gregor Sersa; Branka Strazisar; Damijan Miklavcic; Tomaz Jarm
Journal:  Biomed Eng Online       Date:  2015-08-27       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.